AAV-hTERT

DRUG3 trials

Sponsors

Libella Gene Therapeutics

Conditions

AgingAlzheimer DiseaseCritical Limb Ischemia

Phase 1

Evaluation of Safety and Tolerability of Libella Gene Therapy for Critical Limb Ischemia: AAV- hTERT

Libella Gene TherapeuticsCritical Limb Ischemia

Start: 2019-09-26End: 2020-12-31Target: 5Updated: 2019-10-28

Evaluation of Safety and Tolerability of Libella Gene Therapy for Alzheimer's Disease: AAV- hTERT

Libella Gene TherapeuticsAlzheimer Disease

Start: 2019-10-10End: 2021-01-31Target: 5Updated: 2019-10-28

Evaluation of Safety and Tolerability of Libella Gene Therapy for the Treatment of Aging: AAV- hTERT

Libella Gene TherapeuticsAging

Start: 2019-10-17End: 2021-01-31Target: 5Updated: 2019-12-10